171 related articles for article (PubMed ID: 34711015)
1. CXCL1, CXCL10 and CXCL12 Chemokines are Variously Expressed in Acute Myeloid Leukemia Patients Prior and Post Bone Marrow Transplantation.
Yazdani B; Hassanshahi G; Mousavi Z; Ahmadi Z; Khorramdelazad H; Moradabadi A; Shafiepoor M; Fatehi A
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3377-3384. PubMed ID: 34711015
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of circulating concentrations of CXCL1 (Gro-α), CXCL10 (IP-10) and CXCL12 (SDF-1) in ALL patients prior and post bone marrow transplantation.
Khandany BK; Hassanshahi G; Khorramdelazad H; Balali Z; Shamsizadeh A; Arababadi MK; Ostadebrahimi H; Fatehi A; Rezazadeh M; Ahmadi Z; Karimabad MN
Pathol Res Pract; 2012 Oct; 208(10):615-9. PubMed ID: 22975476
[TBL] [Abstract][Full Text] [Related]
3. Overproduction of CXC chemokines CXCL1, CXCL9, CXCL10 and CXCL12 in β-thalassemia major or patients.
Najmaddini H; Hassanshahi G; Ostadebrahimi H; Barkhordari H; Mashayekhi H; Nazari M; Moogooei M; Arababadi YS; Peighambari F; Karimabad MN
Ann Saudi Med; 2014; 34(2):122-7. PubMed ID: 24894780
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of CXCL1, CXCL9, CXCL10 and CXCL12 chemokines in alopecia areata.
Zainodini N; Hassanshahi G; Arababadi MK; Khorramdelazad H; Mirzaei A
Iran J Immunol; 2013 Mar; 10(1):40-6. PubMed ID: 23502337
[TBL] [Abstract][Full Text] [Related]
5. CXCL9/CXCL10 angiostasis CXC-chemokines in parallel with the CXCL12 as an angiogenesis CXC-chemokine are variously expressed in pre-eclamptic-women and their neonates.
Darakhshan S; Hassanshahi G; Mofidifar Z; Soltani B; Karimabad MN
Pregnancy Hypertens; 2019 Jul; 17():36-42. PubMed ID: 31487653
[TBL] [Abstract][Full Text] [Related]
6. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
[TBL] [Abstract][Full Text] [Related]
7. The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML).
Korbecki J; Kupnicka P; Barczak K; Bosiacki M; Ziętek P; Chlubek D; Baranowska-Bosiacka I
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760523
[TBL] [Abstract][Full Text] [Related]
8. Description of B lymphocytes and plasma cells, complement, and chemokines/receptors in acute liver allograft rejection.
Krukemeyer MG; Moeller J; Morawietz L; Rudolph B; Neumann U; Theruvath T; Neuhaus P; Krenn V
Transplantation; 2004 Jul; 78(1):65-70. PubMed ID: 15257040
[TBL] [Abstract][Full Text] [Related]
9. CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation.
Piper KP; Horlock C; Curnow SJ; Arrazi J; Nicholls S; Mahendra P; Craddock C; Moss PA
Blood; 2007 Dec; 110(12):3827-32. PubMed ID: 17766680
[TBL] [Abstract][Full Text] [Related]
10. Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cells.
Kalinkovich A; Tavor S; Avigdor A; Kahn J; Brill A; Petit I; Goichberg P; Tesio M; Netzer N; Naparstek E; Hardan I; Nagler A; Resnick I; Tsimanis A; Lapidot T
Cancer Res; 2006 Nov; 66(22):11013-20. PubMed ID: 17108140
[TBL] [Abstract][Full Text] [Related]
11. Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12.
Inngjerdingen M; Rolstad B; Ryan JC
J Immunol; 2003 Sep; 171(6):2889-95. PubMed ID: 12960311
[TBL] [Abstract][Full Text] [Related]
12. Homing characteristics of donor T cells after experimental allogeneic bone marrow transplantation and posttransplantation therapy for multiple myeloma.
van der Voort R; Volman TJ; Verweij V; Linssen PC; Maas F; Hebeda KM; Dolstra H
Biol Blood Marrow Transplant; 2013 Mar; 19(3):378-86. PubMed ID: 23266741
[TBL] [Abstract][Full Text] [Related]
13. The chemokine network in acute myelogenous leukemia: molecular mechanisms involved in leukemogenesis and therapeutic implications.
Kittang AO; Hatfield K; Sand K; Reikvam H; Bruserud Ø
Curr Top Microbiol Immunol; 2010; 341():149-72. PubMed ID: 20376612
[TBL] [Abstract][Full Text] [Related]
14. Migration of V delta 1 and V delta 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat.
Poggi A; Carosio R; Fenoglio D; Brenci S; Murdaca G; Setti M; Indiveri F; Scabini S; Ferrero E; Zocchi MR
Blood; 2004 Mar; 103(6):2205-13. PubMed ID: 14630801
[TBL] [Abstract][Full Text] [Related]
15. Human osteoclasts express different CXC chemokines depending on cell culture substrate: molecular and immunocytochemical evidence of high levels of CXCL10 and CXCL12.
Grassi F; Piacentini A; Cristino S; Toneguzzi S; Cavallo C; Facchini A; Lisignoli G
Histochem Cell Biol; 2003 Nov; 120(5):391-400. PubMed ID: 14600836
[TBL] [Abstract][Full Text] [Related]
16. CXCL12 (SDF-1) and CXCL13 (BCA-1) chemokines significantly induce proliferation and collagen type I expression in osteoblasts from osteoarthritis patients.
Lisignoli G; Toneguzzi S; Piacentini A; Cristino S; Grassi F; Cavallo C; Facchini A
J Cell Physiol; 2006 Jan; 206(1):78-85. PubMed ID: 15965952
[TBL] [Abstract][Full Text] [Related]
17. CXCL10/CXCR3 axis is associated with disease activity and the development of mucocutaneous lesions in patients with Behçet's disease.
Lee SJ; Kang SE; Kang EH; Choi BY; Masek-Hammerman K; Syed J; Zhan Y; Neff-Phillips K; Park JK; Lee EY; Lee EB; Song YW
Sci Rep; 2017 Nov; 7(1):14720. PubMed ID: 29116188
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of CXCL10, CXCL11, CXCL12 and CXCL13 chemokines in serum and cerebrospinal fluid in patients with tick borne encephalitis (TBE).
Zajkowska J; Moniuszko-Malinowska A; Pancewicz SA; Muszyńska-Mazur A; Kondrusik M; Grygorczuk S; Swierzbińska-Pijanowska R; Dunaj J; Czupryna P
Adv Med Sci; 2011; 56(2):311-7. PubMed ID: 22008312
[TBL] [Abstract][Full Text] [Related]
19. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
[TBL] [Abstract][Full Text] [Related]
20. Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside.
Cho BS; Kim HJ; Konopleva M
Korean J Intern Med; 2017 Mar; 32(2):248-257. PubMed ID: 28219003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
